Lentiviral vectors derived from simian immunodeficiency virus

Current Topics in Microbiology and Immunology

Volumn 261, Issue , 2002, Pages 53-74

  Didier, Nègre ^a   Cosset, François Loïc ^a  

^a University Lyon i   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOSAFETY; GENE TRANSFER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; HUMANS; LENTIVIRUSES, PRIMATE; SAFETY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANIMALIA; LENTIVIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0036201684     PISSN: 0070217X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Envelope gene of the human endogenous retrovirus HERV-W encodes a functional retrovirus envelope
2. Identification of a cellular cofactor required for infection by feline leukaemia virus
3. Large-scale processing of recombinant retroviruses for gene therapy
4. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes
5. Retrotransposons, endogenous retroviruses, the evolution of retroelements
6. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent
7. Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions
8. HIV-nuclear import: In search of a leader
9. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
10. Active nuclear import of human immunodeficiency virus type I preintegration complexes
11. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
12. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production
13. A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines
14. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
15. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates
16. A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector. One of the packaging constructs, and endogenous retroviral sequences
17. Sequences in the cytoplasmic tail of the gibbon ape leukaemia virus envelope protein that prevent its incorporation into lentoviral vectors
18. Molecular biology and pathogenesis of animal lentivirus infections
19. Efficient gene transfer by a human immunodeficiency virus type (HIV-1)-derived vector utilizing a stable HIV packaging cell line
20. Use of helper cells with two host ranges to generate high-titer retroviral vectors
21. Retroviral retargeting by envelopes expressing an N-terminal binding domain
22. Targeting retrovirus entry
23. High titer packaging cells producing re-combinant retroviruses resistant to human serum
24. A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type RNA genome is essential for replication
25. Cellular distribution and karyophilic properties of matrix, integrase, and vpr proteins from the human and simian immunodeficiency viruses
26. The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent
27. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum
28. Identification of highly attenuated mutants of simian immunodeficiency virus
29. Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma
30. Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and moloney murine leukemia virus
31. A third-generation lentivirus vector with a conditional packaging system
32. Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line
33. HIV-1 regulatory/accessory genes: Keys to unraveling viral and host cell biology
34. A hyperfusogenic Gibbon ape leukemia virus envelope glycoprotein: Targeting of a cytotoxic gene by ligand display
35. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
36. HIV-I infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
37. The simian retroviruses SIV and SRV
38. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors
39. Tat mediates apoptosis in vivo in the rat central nervous system
40. Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon
41. Analysis of ALV based-packaging cell lines for production of contaminant defective viruses
42. Homologous and non-homologous retroviral recombination are both involved in the transfer by infectious particles of defective (ALV)-derived transcomplementing genomes
43. Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus
44. AIDS as a zoonosis: Scientific and public health implications
45. Retroviral display of functional binding domains fused to the amino-terminus of influenza haemagglutinin
46. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
47. Design of retroviral vectors and helper cells for gene therapy
48. Retroviral recombination and reverse transcription
49. Identification of a sequence element immediately upstream of the polypurine tract that is essential for replication of simian immunodeficiency virus
50. Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences
51. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: A possible role for the p2 domain of Gag in RNA encapsidation
52. Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein
53. Generation of replication-efective helper-free vectors based on simian immunodeficiency immunodeficiency virus
54. Use of helper-free replication-defective simian immunodeficiency virus-based vectors to study macrophage and T. tropism: Evidence for distinct levels of restriction in primary macrophages and a T-cell line
55. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
56. Improved methods of retroviral vector transduction and production for gene therapy
57. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene
58. Retargetting gene delivery by surface engineered retroviral vector particles
59. Functional analysis of the simian immunodeficiency virus vpx protein: Identification of packaging determinants and a novel nuclear targeting domain
60. Retroviral-mediated gene transfer into human CD34 +/38- primitive cells capable of reconstituting long-term cultures in vitro and in nonobese diabetic-severe combined immunodeficiency mice in vivo
61. Simian immunodeficiency virus variants: Threat of new lentiviruses
62. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus
63. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at time of infection
64. The cytotoxicity of human immunodeficiency virus type 1 Rev: Implications for its interaction with the nucleolar protein B23
65. High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocol
66. Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system
67. Lentiviruses as gene transfer agents for delivery to non-dividing cells
68. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
69. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells
70. Development of a Rev-independent, minimal simian immunodeficiency virus-derived vector system
71. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells
72. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors
73. Replication-competent chimeric lenti-oncovirus with expanded host cell tropism
74. Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay
75. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type I particles
76. Integration of murine leukemia virus DNA depends on mitosis
77. Defective retroviral endogenous RNA is efficiently transmitted by infectious particles produced on an avian retroviral vector packaging cell line
78. Live attenuated AIDS viruses as vaccines: Promise or peril?
79. Modifying the host range properties of retroviral vectors
80. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors
81. A chimeric GALV-derived envelope glycoprotein harboring the cytoplasmic tail of MLV envelope efficiently pseudotypes HIV-1 vectors
82. Inactivation of the human immunodeficiency virus type I inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation
83. Development of a self-inactivating, minimal lentivirus vector based on simian n immunodeficiency virus
84. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates u a retroviral vector with specificity of infection for CD4-expressing cells
85. Gene delivery systems for use in gene Eerie therapy: An overview of quality cluality assurance and safety issues
86. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines
87. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper belper and gene gone transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery
88. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1
89. Type C retrovirus inactivation by human complement is determined by both the viral genome and producer cell genoine Lind producercell
90. Lentiviral vectors: Turning a deadly foe into a therapeutic agent
91. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells
92. Lentiviral vectors: Excellent tools for experimental gene transfer and promising candidates for gene therapy
93. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: Implications for the safety of vectors
94. Lentivirus vectors using human and simian immunodeficiency virus elements
95. HIV-1 genome nuclear import is mediated by a central DNA flap
96. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus retrovirLIS type 1 in human peripheral blood lymphocytes
97. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo